Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Paciotti

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Gland Surgery|September 21, 2020
The relationship between hospital volume and outcomes of radical prostatectomy: a new perspective on an old storyMarco Paciotti, Vittorio Fasulo, Giovanni Lughezzani
European Urology|April 23, 2026
Re: Kitamura H, Tsukamoto T, Kakehi Y, et al. Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-Grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.01.008Andrea Piccolini, Marco Paciotti, Nicolò M Buffi
The Journal of Urology|May 17, 2023
Current Landscape of Surgical Assessment Models in Urology Residency Training. LetterMarco Paciotti, Anthony G Gallagher, Alexandre Mottrie
Minerva Urology and Nephrology|December 18, 2025
Comment on "Development of novel patient selection algorithm for multi-port versus single-port robotic radical prostatectomy approaches"Gianluca Spena, Paolo Dell'oglio, Marco Paciotti, et al.
European Urology|January 25, 2022
Proficiency-based Progression Training: A Scientific Approach to Learning Surgical SkillsAnthony G Gallagher, Ruben De Groote, Marco Paciotti, et al.
Current Opinion in Urology|March 12, 2019
Gender-specific risk factors for renal cell carcinoma: a systematic reviewGiovanni Lughezzani, Marco Paciotti, Vittorio Fasulo, et al.
Minerva Urology and Nephrology|August 4, 2023
A cost analysis in implementing simulation-based training into a novel urology curriculumClaudia Ebm, Marco Paciotti, Pietro Diana, et al.
BJU International|July 8, 2025
Comment on: 'Residents surgical training using metrics for transurethral resection of bladder tumours'Pietro Diana, Andrea Gallioli, Marco Paciotti, et al.
The Oncologist|March 2, 2021
Temporal Trends and Predictors in the Use of Stereotactic Body Radiotherapy for Treatment of Metastatic Renal Cell Carcinoma in the U.SMarco Paciotti, Andrew L Schmidt, Praful Ravi, et al.
JAMA Oncology|January 14, 2021
Cancer Screening Tests and Cancer Diagnoses During the COVID-19 PandemicZiad Bakouny, Marco Paciotti, Andrew L Schmidt, et al.
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Gland Surgery|September 21, 2020
The relationship between hospital volume and outcomes of radical prostatectomy: a new perspective on an old storyMarco Paciotti, Vittorio Fasulo, Giovanni Lughezzani
European Urology|April 23, 2026
Re: Kitamura H, Tsukamoto T, Kakehi Y, et al. Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-Grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.01.008Andrea Piccolini, Marco Paciotti, Nicolò M Buffi
The Journal of Urology|May 17, 2023
Current Landscape of Surgical Assessment Models in Urology Residency Training. LetterMarco Paciotti, Anthony G Gallagher, Alexandre Mottrie
Minerva Urology and Nephrology|December 18, 2025
Comment on "Development of novel patient selection algorithm for multi-port versus single-port robotic radical prostatectomy approaches"Gianluca Spena, Paolo Dell'oglio, Marco Paciotti, et al.
European Urology|January 25, 2022
Proficiency-based Progression Training: A Scientific Approach to Learning Surgical SkillsAnthony G Gallagher, Ruben De Groote, Marco Paciotti, et al.
Current Opinion in Urology|March 12, 2019
Gender-specific risk factors for renal cell carcinoma: a systematic reviewGiovanni Lughezzani, Marco Paciotti, Vittorio Fasulo, et al.
Minerva Urology and Nephrology|August 4, 2023
A cost analysis in implementing simulation-based training into a novel urology curriculumClaudia Ebm, Marco Paciotti, Pietro Diana, et al.
BJU International|July 8, 2025
Comment on: 'Residents surgical training using metrics for transurethral resection of bladder tumours'Pietro Diana, Andrea Gallioli, Marco Paciotti, et al.
The Oncologist|March 2, 2021
Temporal Trends and Predictors in the Use of Stereotactic Body Radiotherapy for Treatment of Metastatic Renal Cell Carcinoma in the U.SMarco Paciotti, Andrew L Schmidt, Praful Ravi, et al.
JAMA Oncology|January 14, 2021
Cancer Screening Tests and Cancer Diagnoses During the COVID-19 PandemicZiad Bakouny, Marco Paciotti, Andrew L Schmidt, et al.
Pageof 14